Lumida
/CDXS
⌘K
Codexis Inc

Codexis Inc

CDXS
$2.24USD+3.70%+0.08 today

MARKET CAP

203.6M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$1
$4

AI Summary

Stalk
TrimMedium

CDXS remains in a Stage 4 decline with a clear medium-term bearish bias and neutral short-term timing due to extreme oversold conditions. Execution posture is to trim into strength near intermediate resistance defined by the short-term EMAs.

  • Q1 2026 revenues $15.2M (+102.7% YoY) driven by Merck agreement
  • Product gross margin rose to 71% in Q1 from 55% last year
  • Q1 net loss narrowed to $8.7M vs $20.7M prior year, profitability elusive
Full analysis →
Insider Trades11 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Feb 24, 2026SellCDXSStefan LutzChief Scientific Officer5,862$1.13$203.6M-42.12%+133.75%$6.6K-1.30%Sell Now
Feb 6, 2026SellCDXSStefan LutzChief Scientific Officer2,492$1.31$203.6M-42.12%+133.75%$3.3K-1.80%Sell Now
Feb 6, 2026SellCDXSAlison MoorePresident and CEO3,826$1.31$203.6M-42.12%+133.75%$5.0K-1.50%Sell Now
Feb 6, 2026SellCDXSGeorgia Erbez3,826$1.31$203.6M-42.12%+133.75%$5.0K-5.42%Sell Now
Jan 7, 2026SellCDXSStefan LutzCSO4,685$1.70$203.6M-42.12%+133.75%$7.9K-3.27%Sell Now
Oct 13, 2025SellCDXSGeorgia ErbezChief Financial Officer6,239$2.50$203.6M-42.12%+133.75%$15.6K-8.12%Sell Now
Oct 13, 2025SellCDXSAlison MooreChief Technical Officer6,239$2.51$203.6M-42.12%+133.75%$15.6K-3.55%Sell Now
Sep 11, 2023BuyCDXSKevin NorrettChief Operating Officer9,000$1.72$203.6M-42.12%+133.75%$15.5K+10.10%Sell Now
Sep 8, 2023BuyCDXSSriram RyaliChief Financial Officer11,650$1.70$203.6M-42.12%+133.75%$19.9K+10.42%Sell Now
Sep 8, 2023BuyCDXSMargaret Nell Fitzgerald11,834$1.70$203.6M-42.12%+133.75%$20.1K+17.01%Sell Now
Sep 8, 2023BuyCDXSStephen George Dilly58,479$1.73$203.6M-42.12%+133.75%$101.0K+15.37%Sell Now